Expanded testing Leverage Eurofins Viracor BioPharma Services' broad assay catalog of over 3,000 validated tests and ongoing custom assay development to upsell comprehensive infectious disease, immunogenicity, biomarker, and vaccine safety testing for late-stage trials and diverse therapeutic areas.

High throughput capabilities Position their rapid turnaround and scalable, high-volume processing as a selling point for sponsors running large Phase 1–4 trials, emphasizing project management integration as seamless extensions of client laboratories to meet tight timelines.

Technology versatility Target opportunities by highlighting their use of 40+ technology platforms and multi-specimen compatibility to support complex method development, validation, and transfer across multiple platforms for trial-specific needs.

Strategic partnerships Promote their R&D team as an extension of clients’ labs to accelerate study designs, protocol optimization, and assay transfer, appealing to sponsors seeking collaborative, end-to-end testing partnerships.

Global capabilities plus security Emphasize compliance (ISO/IEC 27001, security certifications) and robust cyber and data protection as a differentiator for CRO partnerships handling sensitive clinical trial data across infectious disease, immunology, and biomarker programs.